O-51 Phase III study (TAX 326) of docetaxel-cisplatin (DC) and docetaxel-carboplatin (DCB) versus vinorelbine-cisplatin (VC) for the first-line treatment of advanced/metastatic non-small cell lung cancer (NSCLC): analyses in elderly patients
Keyword(s):
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 3-3
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S340-S341
◽
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 7
(3)
◽
pp. 6
◽
Keyword(s):
2017 ◽
Vol 18
(4)
◽
pp. e289-e296
◽
Keyword(s):